These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35732910)

  • 21. Delineation of chemsex patterns of men who have sex with men in association with their sexual networks and linkage to HIV prevention.
    Wong NS; Kwan TH; Lee KCK; Lau JYC; Lee SS
    Int J Drug Policy; 2020 Jan; 75():102591. PubMed ID: 31756695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do pre-exposure prophylaxis (PrEP) users engaging in chemsex experience their participation as problematic and how can they best be supported? Findings from an online survey in Belgium.
    Vanbaelen T; Rotsaert A; Van Landeghem E; Nöstlinger C; Vuylsteke B; Platteau T; Herrijgers C; Reyniers T
    Sex Health; 2023 Oct; 20(5):424-430. PubMed ID: 37487323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chems4EU: chemsex use and its impacts across four European countries in HIV-positive men who have sex with men attending HIV services.
    Whitlock GG; Protopapas K; Bernardino JI; Imaz A; Curran A; Stingone C; Shivasankar S; Edwards S; Herbert S; Thomas K; Mican R; Prieto P; Nestor Garcia J; Andreoni M; Hill S; Okhai H; Stuart D; Bourne A; Conway K
    HIV Med; 2021 Nov; 22(10):944-957. PubMed ID: 34432363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Daily use of HIV pre-exposure prophylaxis among gay, bisexual and other men who have sex with men in Spain: Prevalence and associated factors.
    Moreno-García S; Belza MJ; Iniesta C; González-Recio P; Palma D; Sordo L; Pulido J; Guerras JM
    Med Clin (Barc); 2024 Feb; 162(3):95-102. PubMed ID: 37813725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization of mental health services in relation to the intention to reduce chemsex behavior among clients from an integrated sexual health services center in Taiwan.
    Hung YR; Chuang TT; Chen TW; Chung AC; Wu MT; Hsu ST; Ko NY; Strong C
    Harm Reduct J; 2023 Apr; 20(1):52. PubMed ID: 37062840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Destabilising the 'problem' of chemsex: Diversity in settings, relations and practices revealed in Australian gay and bisexual men's crystal methamphetamine use.
    Drysdale K; Bryant J; Hopwood M; Dowsett GW; Holt M; Lea T; Aggleton P; Treloar C
    Int J Drug Policy; 2020 Apr; 78():102697. PubMed ID: 32065931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemsex in Italy: Experiences of Men Who Have Sex With Men Consuming Illicit Drugs to Enhance and Prolong Their Sexual Activity.
    Nimbi FM; Rosati F; Esposito RM; Stuart D; Simonelli C; Tambelli R
    J Sex Med; 2020 Oct; 17(10):1875-1884. PubMed ID: 32727698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How can those engaging in chemsex best be supported? An online survey to gain intelligence in Greater Manchester.
    Tomkins A; Vivancos R; Ward C; Kliner M
    Int J STD AIDS; 2018 Feb; 29(2):128-134. PubMed ID: 28691863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemsex and diagnoses of syphilis, gonorrhoea and chlamydia among men who have sex with men in the UK: a multivariable prediction model using causal inference methodology.
    MacGregor L; Kohli M; Looker KJ; Hickson F; Weatherburn P; Schmidt AJ; Turner KM
    Sex Transm Infect; 2021 Jun; 97(4):282-289. PubMed ID: 33452129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemsex and antiretroviral prescribing in an HIV cohort in Brighton, UK.
    Adler Z; Fitzpatrick C; Broadwell N; Churchill D; Richardson D
    HIV Med; 2022 Aug; 23(7):797-800. PubMed ID: 35048490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Chemsex" and harm reduction need among gay men in South London.
    Bourne A; Reid D; Hickson F; Torres-Rueda S; Steinberg P; Weatherburn P
    Int J Drug Policy; 2015 Dec; 26(12):1171-6. PubMed ID: 26298332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement.
    Laguno M; Ugarte A; Martinez-Rebollar M; Sobrino Y; Font G; de Lazzari E; de la Mora L; Torres B; Chivite I; Riera J; Ambrosioni J; Inciarte A; Gonzalez-Cordon A; Rojas J; Cordon E; Blanco JL; Martinez E; Mallolas J
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 Jan; 41(1):24-28. PubMed ID: 35810144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV pre-exposure prophylaxis and diagnoses of sexually transmitted infections - observational data from German checkpoints, 01/2019-08/2021.
    Marcus U; Schink SB; Weber C
    BMC Public Health; 2023 Apr; 23(1):661. PubMed ID: 37029369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sexualized drug use among men who have sex with men in Madrid and Barcelona: The gateway to new drug use?
    Guerras JM; Hoyos J; Donat M; de la Fuente L; Palma Díaz D; Ayerdi O; García-Pérez JN; García de Olalla P; Belza MJ
    Front Public Health; 2022; 10():997730. PubMed ID: 36457321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-exposure Prophylaxis Awareness and Use Among Cisgender Men Who Have Sex With Men and Use Methamphetamine in 3 Western US Cities.
    McMahan VM; Moreno C; Al-Tayyib A; Menza TW; Orellana ER; Bhattarai A; Stekler JD; Glick SN
    Sex Transm Dis; 2020 Apr; 47(4):217-223. PubMed ID: 31923138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can We Predict Incorrect PrEP Use in High HIV Risk Situations Among Men Who Have Sex With Men? An Analysis of Be-PrEP-ared, the Belgian PrEP Demonstration Study.
    Vuylsteke B; Reyniers T; Nöstlinger C; Smekens T; Kenyon C; Laga M
    J Acquir Immune Defic Syndr; 2021 Sep; 88(1):36-44. PubMed ID: 34081665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with methamphetamine dependency among men who have sex with men engaging in chemsex: Findings from the COMeT study in Taiwan.
    Li CW; Ku SW; Huang P; Chen LY; Wei HT; Strong C; Bourne A
    Int J Drug Policy; 2021 Jul; 93():103119. PubMed ID: 33468444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemsex in HIV pre-exposure prophylaxis users: Assessment of mood disorders and addictive behavior.
    Peyriere H; Jacquet JM; Peries M; Tribout V; Broche B; Mauboussin JM; Makinson A; Perrollaz C; Ferreyra M; Rouanet I; Montoya-Ferrer A; El-Majjaoui S; Corriol-Bonifas F; Fraisse T; Grau F; Laureillard D; Nagot N; Reynes J; Donnadieu-Rigole H
    Fundam Clin Pharmacol; 2023 Jun; 37(3):639-649. PubMed ID: 36403123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal Methamphetamine Use in Sexual Settings Among German Men Who Have Sex With Men.
    Schecke H; Lea T; Bohn A; Köhler T; Sander D; Scherbaum N; Deimel D
    Front Psychiatry; 2019; 10():886. PubMed ID: 31866883
    [No Abstract]   [Full Text] [Related]  

  • 40. Factors associated with PrEP-era HIV seroconversion in a 4-year U.S. national cohort of n = 6059 sexual and gender minority individuals who have sex with men, 2017-2022.
    Grov C; Guo Y; Westmoreland DA; D'Angelo AB; Mirzayi C; Dearolf M; Carneiro P; Ray M; Pantalone D; Carrico AW; Patel VV; Golub SA; Hirshfield S; Hoover DR; Nash D
    J Int AIDS Soc; 2024 Jun; 27(6):e26312. PubMed ID: 38924359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.